How Armor Thyroid Works
Armor Thyroid is a desiccated porcine thyroid extract that functions as a combination thyroid hormone replacement, delivering both levothyroxine (T4) and liothyronine (T3) in an approximately 4:1 ratio by weight, which directly replaces deficient thyroid hormones in hypothyroid patients. 1
Mechanism of Action
Armor Thyroid provides 38 mcg of levothyroxine (T4) and 9 mcg of liothyronine (T3) per grain of thyroid extract 1. This dual-hormone delivery works through two pathways:
- T4 (levothyroxine) acts as a prohormone with a long half-life, providing steady baseline thyroid hormone levels that are peripherally converted to the active T3 form
- T3 (liothyronine) is the biologically active thyroid hormone that directly binds to nuclear thyroid receptors, regulating metabolism, protein synthesis, and cellular energy production
The bioavailability of T3 in desiccated thyroid is comparable to synthetic liothyronine, meaning the T3 component is rapidly absorbed and immediately active 2.
Pharmacological Considerations
The T4/T3 ratio in Armor Thyroid is approximately 4:1 by weight (or roughly 2.9-4.3 molar ratio depending on the lot) 2, 3. This differs substantially from the physiologic thyroid gland secretion and from synthetic levothyroxine monotherapy, where the body relies entirely on peripheral conversion of T4 to T3.
Key Pharmacokinetic Features:
- Rapid T3 absorption: The T3 component is absorbed quickly, leading to peak serum T3 levels within hours of ingestion 4, 5
- Variable hormone content: The ratio of T4 to T3 may vary between lots and brands of desiccated thyroid preparations 2
- Higher T3 exposure: Patients on DTE consistently show significantly higher total T3 levels and lower T4 levels compared to levothyroxine monotherapy 4
Clinical Effects
Studies demonstrate that Armor Thyroid treatment results in:
- Elevated serum T3 levels (mean difference +50.90 compared to T4 monotherapy) 4
- Reduced serum T4 and free T4 levels (mean difference -3.11 for total T4) 4
- Modestly higher TSH levels (mean difference +0.49) compared to levothyroxine alone 4
Important Caveats
Major guideline organizations explicitly recommend against using desiccated thyroid hormone for hypothyroidism treatment 2. The 2012 AACE/ATA guidelines state there is "no evidence to support using desiccated thyroid hormone in preference to L-thyroxine monotherapy" (Grade D recommendation) 2.
Critical Limitations:
- Lack of systematic study: Desiccated thyroid has not been systematically studied in rigorous clinical trials 2
- No quality of life benefit: Recent meta-analyses show no significant improvement in quality of life scores, depression scales, or symptom questionnaires compared to levothyroxine 4, 6
- Potential cardiovascular concerns: The rapid T3 absorption can cause transient hypertriiodothyroninemia, potentially increasing heart rate and cardiovascular stress 6, 5
- Product consistency issues: DTE remains outside formal FDA oversight for hormone content consistency, with monitoring performed only by manufacturers 5
- Contamination risk: As a porcine-derived product, theoretical risk of viral or adventitious agent contamination exists, though no cases have been reported 1
When Patients Request It:
Despite guideline recommendations, some patients report subjective preference for DTE. If considering a trial after failed levothyroxine optimization:
- Ensure TSH normalization first with levothyroxine monotherapy
- Rule out other causes of persistent symptoms (psychosocial factors, comorbidities, unrealistic expectations) 7
- Consider genetic testing for DIO2 polymorphisms that may impair T4-to-T3 conversion 8
- Monitor closely for signs of overtreatment (tachycardia, weight loss, bone loss)
- Recognize that only 5% of endocrinologists use DTE for their own hypothyroidism, compared to 16% who use synthetic T4/T3 combinations 7
The standard of care remains levothyroxine monotherapy 2, 5. Armor Thyroid works by providing exogenous thyroid hormones, but lacks evidence demonstrating superiority in patient-centered outcomes compared to the established standard treatment.